Cansortium Valuation
| CNTMF Stock | USD 0.11 0.02 18.28% |
Cansortium seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cansortium from analyzing the firm fundamentals such as Profit Margin of (0.29) %, current valuation of 118.5 M, and Return On Equity of -0.28 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Cansortium's price fluctuation is out of control at this time. Calculation of the real value of Cansortium is based on 3 months time horizon. Increasing Cansortium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cansortium otc stock is determined by what a typical buyer is willing to pay for full or partial control of Cansortium. Since Cansortium is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cansortium OTC Stock. However, Cansortium's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.11 | Real 0.1 | Hype 0.11 | Naive 0.14 |
The real value of Cansortium OTC Stock, also known as its intrinsic value, is the underlying worth of Cansortium OTC Stock, which is reflected in its stock price. It is based on Cansortium's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cansortium's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cansortium helps investors to forecast how Cansortium otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cansortium more accurately as focusing exclusively on Cansortium's fundamentals will not take into account other important factors: Cansortium Total Value Analysis
Cansortium is currently expected to have takeover price of 118.5 M with market capitalization of 33.24 M, debt of 53.67 M, and cash on hands of 8.86 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cansortium fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
118.5 M | 33.24 M | 53.67 M | 8.86 M |
Cansortium Investor Information
About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cansortium recorded a loss per share of 0.1. The entity had not issued any dividends in recent years. Cansortium is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Cansortium Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cansortium has an asset utilization ratio of 35.86 percent. This implies that the OTC Stock is making $0.36 for each dollar of assets. An increasing asset utilization means that Cansortium is more efficient with each dollar of assets it utilizes for everyday operations.Cansortium Ownership Allocation
Cansortium holds a total of 225.38 Million outstanding shares. Cansortium retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cansortium Profitability Analysis
The company reported the revenue of 65.44 M. Net Loss for the year was (19.04 M) with profit before overhead, payroll, taxes, and interest of 35.79 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cansortium's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cansortium and how it compares across the competition.
About Cansortium Valuation
The otc valuation mechanism determines Cansortium's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cansortium. We calculate exposure to Cansortium's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cansortium's related companies.Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida. Cansortium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Cansortium's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Cansortium's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cansortium's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cansortium's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cansortium's revenue streams: Identify Cansortium's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cansortium's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cansortium's growth potential: Evaluate Cansortium's management, business model, and growth potential.
- Determine Cansortium's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cansortium's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cansortium Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cansortium does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 252 M | |
| Forward Price Earnings | 1.4372 | |
| Retained Earnings | -157.6 M |
Complementary Tools for Cansortium OTC Stock analysis
When running Cansortium's price analysis, check to measure Cansortium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansortium is operating at the current time. Most of Cansortium's value examination focuses on studying past and present price action to predict the probability of Cansortium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansortium's price. Additionally, you may evaluate how the addition of Cansortium to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |